Skip to content

Fcpm III Services B.V. 13F Holdings · Q2 2026

Fcpm III Services B.V. reported 11 securities worth $750.41M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: NAMS (38.34%), MPLT (15.41%), DYN (11.39%). Among its top 25 positions this quarter: 1 new, 2 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1NAMSNEWAMSTERDAM PHARMA COMPANY$287.7M38.34%8.5MTrimmed
2MPLTMAPLIGHT THERAPEUTICS INC$115.6M15.41%3.2MHold
3DYNDYNE THERAPEUTICS INC$85.5M11.39%3.8MTrimmed
4VORVOR BIOPHARMA INC$75.8M10.10%4.1MHold
5DMRADAMORA THERAPEUTICS INC$63.5M8.46%2.4MHold
6REPLREPLIMUNE GROUP INC$31.1M4.14%2.8MHold
7CBIOCRESCENT BIOPHARMA INC.$30.2M4.02%1.7MHold
8AURAAURA BIOSCIENCES INC$28.8M3.84%4.1MNew
9ENGNENGENE HOLDINGS INC$16.7M2.22%9.6MHold
10BCYCBICYCLE THERAPEUTICS PLC$14.7M1.96%3.5MHold
11ENGNWENGENE HOLDINGS INC$834,3760.11%2.9MHold

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR